Comparison of 3-Factor Prothrombin Complex Concentrate and Low-Dose Recombinant Factor VIIa for Warfarin Reversal

World Journal of Emergency Surgery - United Kingdom
doi 10.1186/1749-7922-9-27
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Three- Versus Four-Factor Prothrombin Complex Concentrate for the Reversal of Warfarin-Induced Bleeding

International Journal of Critical Illness and Injury Science
Emergency MedicinePublic HealthCritical CareEnvironmentalIntensive Care MedicineOccupational Health
2018English

Recombinant Factor VIIa for Reversal of Warfarin Anticoagulation in Intracranial Hemorrhage

Surgery for Cerebral Stroke
2012English

Four-Factor Prothrombin Complex Concentrate (Beriplex® P/N) Is Superior to Three-Factor Prothrombin Complex Concentrate for Reversal of Coumarin Anticoagulation

Critical Care
Critical CareIntensive Care Medicine
2015English

Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared to Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Safety of 4-Factor Prothrombin Complex Concentrate (4f-Pcc) for Emergent Reversal of Factor Xa Inhibitors

Journal of Intensive Care
Critical CareIntensive Care Medicine
2018English

Prothrombin Complex Concentrate

Reactions Weekly
2016English

Recombinant Factor VIIa Plus Surgery for Intracerebral Hemorrhage

Canadian Journal of Neurological Sciences
MedicineNeurology
2008English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy